Related Experiment Videos
[Ambulatory ECG in cardiomyopathies]
1Divisione di Cardiologia, Ospedale Maggiore e Università, Trieste.
Insights
Electrocardiographic monitoring detects frequent arrhythmias in dilated and hypertrophic cardiomyopathies. Antiarrhythmic therapy, like amiodarone, effectively reduces ventricular arrhythmias and improves patient outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Conduction and rhythm disturbances are common in dilated cardiomyopathy (DCM).
- Ventricular arrhythmias and tachycardia are prevalent in hypertrophic cardiomyopathy (HCM), posing a sudden death risk.
- Restrictive cardiomyopathy (RCM) presents with various rhythm and conduction abnormalities.
Purpose of the Study:
- To assess the prevalence of arrhythmias in cardiomyopathy patients.
- To evaluate the correlation between arrhythmias and disease severity/prognosis.
- To determine the efficacy of antiarrhythmic therapy in managing these conditions.
Main Methods:
- 24-hour electrocardiographic monitoring in 65 DCM patients.
- Analysis of arrhythmia incidence, complexity, and correlation with cardiac dysfunction.
- Evaluation of antiarrhythmic therapy (amiodarone) effects.
Main Results:
- 95.4% of DCM patients had ventricular arrhythmias; 44% had non-sustained ventricular tachycardia.
- Complex ventricular arrhythmias and frequent extrasystoles correlated with worse prognosis in DCM.
- Amiodarone significantly reduced ventricular extrasystoles and complex arrhythmias in DCM patients.
- In HCM, amiodarone reduced ventricular extrasystoles and tachycardia, potentially preventing sudden death.
Conclusions:
- Electrocardiographic monitoring is crucial for managing cardiomyopathy patients.
- It aids in identifying at-risk individuals and monitoring antiarrhythmic treatment efficacy.
- Early detection and management of arrhythmias can improve prognosis in cardiomyopathies.
Abstract:
DILATED CARDIOMYOPATHY - Conduction and rhythm disturbances are frequent findings in dilated cardiomyopathy. 65 patients with dilated cardiomyopathy underwent 24-hour electrocardiographic monitoring: 95.4% showed ventricular arrhythmias, 80% complex ventricular arrhythmias and 44% runs of non-sustained ventricular tachycardia. Over 1000 ventricular extrasystoles in 24 hours were present in 44% of cases. Ventricular tachycardia and multiform and paired ventricular extrasystoles correlated significantly with the severity of cardiac dysfunction and with a worse prognosis. Patients undergoing antiarrhythmic therapy (amiodarone) showed a significant reduction in the number of ventricular extrasystoles and in the incidence of complex ventricular arrhythmias. HYPERTROPHIC CARDIOMYOPATHY - The high incidence of arrhythmias, particularly ventricular arrhythmias (approx. 70% of cases) in hypertrophic cardiomyopathy is well recognized: episodes of ventricular tachycardia are present in 20% of cases and are related to an elevated risk of sudden death. Antiarrhythmic treatment with amiodarone significantly reduces the number of ventricular extrasystoles and the episodes of ventricular tachycardia, may prevent sudden death and improve survival. RESTRICTIVE CARDIOMYOPATHY - Very little information is present in literature concerning this extremely rare form, in which every type of rhythm and conduction disturbance has been observed. CONCLUSIONS - Electrocardiographic monitoring is nowadays a very important tool in the management of cardiomyopathy patients, to identify possible patients at risk and to monitor the antiarrhythmic treatment.